Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07242651

Tension and Trauma Releasing Exercises on Hypertensive Patients

The aim of this study is to investigate the effect of Tension and Trauma Releasing Exercises (TRE) on the quality of life and sleep in hypertensive patients. Participants will perform a series of supervised TRE sessions, and their sleep quality, and quality of life will be assessed before and after the intervention to determine any potential improvements related to the exercise.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

50 year–65 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Faculty of physical therapy ,Cairo University

Giza, Egypt

Location contact

Youmna Gamal Elsayed, BSc. in Physical Therapy

CONTACT

[email protected]

+201273150655

About this study

Forty females have had essential hypertension for at least five years. They will be recruited from the outpatient clinic at physical therapy, Cairo university.

The patients of this study will be randomly assigned into 2 equal groups (n=40):

Study Group A: (20 patients) Will receive Tension and Trauma Releasing Exercises in addition to medical treatment programme.

Control Group B: (20 patients) will receive only the Medical treatment programme.

The program of treatment for the study group will be applied 30 minutes per session , with a maximum of 15 minutes of neurogenic tremors, 3 times per week for 8 consecutive weeks.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Participants will be between 50 and 65 years of age.
  • The BMI of patients will range between 30 and 34.9.
  • Patients included in the study were diagnosed with essential hypertension for at least five years.
  • The patients will be in stage 1 hypertension under medical control, characterized by systolic blood pressure ranging from 140 to 159 mmHg and diastolic blood pressure ranging from 90 to 99 mmHg.

Exclusion criteria

  • Patients suffering from any unstable cardiovascular condition, such as uncontrolled arrhythmias or recent myocardial infarction.
  • Patients are diagnosed with secondary hypertension.
  • Patients with cognitive or physical impairments that prevent them from following instructions.

e) Patients who are taking beta-blockers and alpha-blockers because these medications may affect heart rate.

f) Individuals with endocrine disorders or any condition known to influence hormonal levels.

g) Patients are smokers. h) Malignant hypertension.

Treatment and study plan

Tension and trauma releasing exercises

Behavioral

Tension and trauma releasing exercises will be conducted for study group only as follows: The exercises start by slightly fatiguing specific muscle groups to encourage this involuntary shaking, which is considered healthy and calming.

The first exercise: Feet roll gently outward while shifting weight side to side, helping release ankle tension.

The second exercise: One foot steps back while the front heel lifts until the calf feels lightly tired, triggering a small shake.

The third exercise: A small lunge-like position engages the thighs and hips, leading to natural muscle release.

The fourth exercise: A soft bend at the hips with relaxed arms and deep breathing stretches the back and encourages loosening.

The fifth exercise: With feet wide and hands on the lower back, the hips push forward slightly while breathing deeply and turning gently side to side.

The sixth exercise: The body slides into a seated position against a wall to lightly fatigue the

Primary outcomes

  1. Quality of life ,assessed by SF12

    Time frame: Baseline and after 8 weeks of intervention

    Change in SF-12 physical and mental component summary scores from baseline to 8 weeks.

  2. Sleep quality, assessed by the Pittsburgh Sleep Quality Index (PSQI).

    Time frame: Baseline and 8 weeks after the start of the intervention

    Change in global PSQI score from baseline to 8 weeks. PSQI will be administered to assess sleep quality .

Secondary outcomes

  1. Blood pressure - Systolic and Diastolic (mmHg) ,assessed by mercury sphygmomanometer

    Time frame: Baseline and 8 weeks after the start of the intervention

    Mean change in systolic and diastolic blood pressure. Measurements will be taken using a mercury sphygmomanometer after a 5-minute rest period, and the average of two consecutive readings will be recorded.

  2. Heart rate ,assessed by pulse oximeter

    Time frame: Baseline and 8 weeks after the start of the intervention

    change in resting heart rate measured by pulse oximeter

  3. Depression and anxiety ,assessed by Hospital Anxiety and Depression Scale (HADS)

    Time frame: Baseline and 8 weeks after the start of the intervention

    Change in subscale (anxiety and depression) scores from baseline to 8 weeks.

  4. Rate Pressure Product measurement

    Time frame: Baseline and 8 weeks after the start of the intervention

    Heart rate * systolic blood pressure

Study contacts

Contact information is provided by the study sponsor or research team.

Youmna Gamal Elsayed, B.Sc. in Physical Therapy

CONTACT

[email protected]

+201273150655 ext. +201223348743

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Official study title

Effect of Tension and Trauma Releasing Exercises on Quality of Life and Sleep in Patients With Hypertension

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Nov 21, 2025
Registry last updated
Nov 21, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.